![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LINC02315 |
Gene summary for LINC02315 |
![]() |
Gene information | Species | Human | Gene symbol | LINC02315 | Gene ID | 644919 |
Gene name | long intergenic non-protein coding RNA 2315 | |
Gene Alias | LINC02315 | |
Cytomap | 14q21.1 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
644919 | LINC02315 | RNA-P23T2-P23T2-4 | Human | Lung | MIAC | 2.58e-05 | 1.03e+00 | -0.0272 |
644919 | LINC02315 | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 1.16e-38 | 9.97e-01 | -0.0166 |
644919 | LINC02315 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 3.30e-45 | 1.08e+00 | -0.0132 |
644919 | LINC02315 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 2.07e-48 | 1.11e+00 | -0.013 |
644919 | LINC02315 | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 1.40e-44 | 1.09e+00 | -0.0121 |
644919 | LINC02315 | HTA12-26-1 | Human | Pancreas | PDAC | 4.06e-06 | 5.63e-01 | 0.3728 |
644919 | LINC02315 | HTA12-29-1 | Human | Pancreas | PDAC | 9.26e-04 | 2.36e-01 | 0.3722 |
644919 | LINC02315 | HTA12-9-1 | Human | Pancreas | PDAC | 2.52e-07 | 5.18e-01 | 0.1532 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |